Medical - Instruments & Supplies
Compare Stocks
5 / 10Stock Comparison
WST vs ATR vs GTLS vs SEE vs AMCR
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Instruments & Supplies
Industrial - Machinery
Packaging & Containers
Packaging & Containers
WST vs ATR vs GTLS vs SEE vs AMCR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Medical - Instruments & Supplies | Medical - Instruments & Supplies | Industrial - Machinery | Packaging & Containers | Packaging & Containers |
| Market Cap | $23.20B | $8.05B | $9.93B | $6.21B | $18.45B |
| Revenue (TTM) | $3.22B | $3.87B | $4.26B | $5.36B | $22.19B |
| Net Income (TTM) | $543M | $387M | $40M | $506M | $678M |
| Gross Margin | 36.2% | 21.9% | 32.6% | 29.8% | 18.5% |
| Operating Margin | 20.7% | 13.0% | 8.5% | 13.5% | 6.4% |
| Forward P/E | 37.3x | 22.5x | 16.4x | 12.4x | 10.1x |
| Total Debt | $417M | $1.53B | $3.74B | $4.10B | $15.01B |
| Cash & Equiv. | $791M | $402M | $366M | $344M | $827M |
WST vs ATR vs GTLS vs SEE vs AMCR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| West Pharmaceutical… (WST) | 100 | 149.0 | +49.0% |
| AptarGroup, Inc. (ATR) | 100 | 112.3 | +12.3% |
| Chart Industries, I… (GTLS) | 100 | 528.4 | +428.4% |
| Sealed Air Corporat… (SEE) | 100 | 131.0 | +31.0% |
| Amcor plc (AMCR) | 100 | 391.1 | +291.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: WST vs ATR vs GTLS vs SEE vs AMCR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
WST is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 6.3%, EPS growth 1.6%, 3Y rev CAGR 2.1%
- 16.9% margin vs GTLS's 0.9%
- 13.2% ROA vs GTLS's 0.4%, ROIC 17.5% vs 7.4%
ATR ranks third and is worth considering specifically for income & stability and sleep-well-at-night.
- Dividend streak 33 yrs, beta 0.66, yield 1.4%
- Lower volatility, beta 0.66, Low D/E 56.4%, current ratio 1.62x
- PEG 1.75 vs SEE's 9.73
- Better valuation composite
GTLS is the clearest fit if your priority is long-term compounding.
- 7.7% 10Y total return vs AMCR's 417.0%
SEE is the clearest fit if your priority is defensive.
- Beta 0.32, yield 1.9%, current ratio 0.91x
- Beta 0.32 vs WST's 0.92
AMCR carries the broadest edge in this set and is the clearest fit for growth and dividends.
- 10.0% revenue growth vs SEE's -0.6%
- 6.6% yield, 11-year raise streak, vs ATR's 1.4%
- +366.6% vs ATR's -16.1%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 10.0% revenue growth vs SEE's -0.6% | |
| Value | Better valuation composite | |
| Quality / Margins | 16.9% margin vs GTLS's 0.9% | |
| Stability / Safety | Beta 0.32 vs WST's 0.92 | |
| Dividends | 6.6% yield, 11-year raise streak, vs ATR's 1.4% | |
| Momentum (1Y) | +366.6% vs ATR's -16.1% | |
| Efficiency (ROA) | 13.2% ROA vs GTLS's 0.4%, ROIC 17.5% vs 7.4% |
WST vs ATR vs GTLS vs SEE vs AMCR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
WST vs ATR vs GTLS vs SEE vs AMCR — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
WST leads in 2 of 6 categories
SEE leads 1 • AMCR leads 1 • ATR leads 0 • GTLS leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
WST leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
AMCR is the larger business by revenue, generating $22.2B annually — 6.9x WST's $3.2B. WST is the more profitable business, keeping 16.9% of every revenue dollar as net income compared to GTLS's 0.9%. On growth, AMCR holds the edge at +77.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $3.2B | $3.9B | $4.3B | $5.4B | $22.2B |
| EBITDAEarnings before interest/tax | $794M | $801M | $644M | $965M | $2.6B |
| Net IncomeAfter-tax profit | $543M | $387M | $40M | $506M | $678M |
| Free Cash FlowCash after capex | $458M | $325M | $203M | $459M | $1.4B |
| Gross MarginGross profit ÷ Revenue | +36.2% | +21.9% | +32.6% | +29.8% | +18.5% |
| Operating MarginEBIT ÷ Revenue | +20.7% | +13.0% | +8.5% | +13.5% | +6.4% |
| Net MarginNet income ÷ Revenue | +16.9% | +10.0% | +0.9% | +9.4% | +3.1% |
| FCF MarginFCF ÷ Revenue | +14.2% | +8.4% | +4.8% | +8.6% | +6.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | +21.0% | +10.8% | -2.5% | +2.1% | +77.4% |
| EPS Growth (YoY)Latest quarter vs prior year | +56.1% | -4.3% | -36.1% | +16.4% | -11.8% |
Valuation Metrics
SEE leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 12.3x trailing earnings, SEE trades at a 98% valuation discount to GTLS's 628.5x P/E. Adjusting for growth (PEG ratio), ATR offers better value at 1.65x vs SEE's 9.66x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $23.2B | $8.1B | $9.9B | $6.2B | $18.4B |
| Enterprise ValueMkt cap + debt − cash | $22.8B | $9.2B | $13.3B | $10.0B | $32.6B |
| Trailing P/EPrice ÷ TTM EPS | 47.33x | 21.28x | 628.45x | 12.29x | 24.96x |
| Forward P/EPrice ÷ next-FY EPS est. | 37.34x | 22.47x | 16.40x | 12.38x | 10.13x |
| PEG RatioP/E ÷ EPS growth rate | 5.72x | 1.65x | — | 9.66x | — |
| EV / EBITDAEnterprise value multiple | 30.77x | 11.48x | 14.33x | 14.33x | 18.85x |
| Price / SalesMarket cap ÷ Revenue | 7.55x | 2.13x | 2.33x | 1.16x | 1.23x |
| Price / BookPrice ÷ Book value/share | 7.37x | 3.08x | 2.79x | 5.02x | 1.08x |
| Price / FCFMarket cap ÷ FCF | 49.48x | 26.89x | 48.95x | 13.54x | 22.78x |
Profitability & Efficiency
WST leads this category, winning 8 of 9 comparable metrics.
Profitability & Efficiency
SEE delivers a 48.4% return on equity — every $100 of shareholder capital generates $48 in annual profit, vs $1 for GTLS. WST carries lower financial leverage with a 0.13x debt-to-equity ratio, signaling a more conservative balance sheet compared to SEE's 3.31x. On the Piotroski fundamental quality scale (0–9), WST scores 6/9 vs AMCR's 5/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +17.9% | +18.6% | +1.2% | +48.4% | +3.7% |
| ROA (TTM)Return on assets | +13.2% | +7.6% | +0.4% | +7.1% | +1.8% |
| ROICReturn on invested capital | +17.5% | +10.7% | +7.4% | +11.2% | +4.1% |
| ROCEReturn on capital employed | +18.4% | +13.8% | +8.6% | +14.1% | +4.8% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 | 5 | 5 | 5 |
| Debt / EquityFinancial leverage | 0.13x | 0.56x | 1.11x | 3.31x | 1.28x |
| Net DebtTotal debt minus cash | -$375M | $1.1B | $3.4B | $3.8B | $14.2B |
| Cash & Equiv.Liquid assets | $791M | $402M | $366M | $344M | $827M |
| Total DebtShort + long-term debt | $417M | $1.5B | $3.7B | $4.1B | $15.0B |
| Interest CoverageEBIT ÷ Interest expense | 3338.00x | 16.19x | 1.08x | 1.95x | 2.85x |
Total Returns (Dividends Reinvested)
AMCR leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in AMCR five years ago would be worth $42,012 today (with dividends reinvested), compared to $8,088 for SEE. Over the past 12 months, AMCR leads with a +366.6% total return vs ATR's -16.1%. The 3-year compound annual growth rate (CAGR) favors AMCR at 65.6% vs WST's -4.0% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +16.6% | +2.9% | +0.6% | +2.0% | +382.5% |
| 1-Year ReturnPast 12 months | +51.4% | -16.1% | +37.6% | +44.2% | +366.6% |
| 3-Year ReturnCumulative with dividends | -11.6% | +7.4% | +62.7% | +2.4% | +354.2% |
| 5-Year ReturnCumulative with dividends | -2.4% | -15.3% | +29.5% | -19.1% | +320.1% |
| 10-Year ReturnCumulative with dividends | +361.4% | +83.3% | +772.5% | +4.4% | +417.0% |
| CAGR (3Y)Annualised 3-year return | -4.0% | +2.4% | +17.6% | +0.8% | +65.6% |
Risk & Volatility
Evenly matched — GTLS and SEE each lead in 1 of 2 comparable metrics.
Risk & Volatility
SEE is the less volatile stock with a 0.32 beta — it tends to amplify market swings less than WST's 0.92 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. GTLS currently trades 99.5% from its 52-week high vs ATR's 76.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.92x | 0.66x | 0.56x | 0.32x | 0.80x |
| 52-Week HighHighest price in past year | $323.63 | $164.28 | $208.51 | $44.27 | $50.94 |
| 52-Week LowLowest price in past year | $202.79 | $103.23 | $140.50 | $28.15 | $7.67 |
| % of 52W HighCurrent price vs 52-week peak | +99.5% | +76.2% | +99.5% | +95.2% | +78.4% |
| RSI (14)Momentum oscillator 0–100 | 73.2 | 42.8 | 51.2 | 64.0 | 52.3 |
| Avg Volume (50D)Average daily shares traded | 835K | 473K | 1.6M | 3.0M | 5.5M |
Analyst Outlook
Evenly matched — ATR and AMCR each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: WST as "Buy", ATR as "Buy", GTLS as "Buy", SEE as "Buy", AMCR as "Buy". Consensus price targets imply 35.6% upside for ATR (target: $170) vs -6.5% for GTLS (target: $194). For income investors, AMCR offers the higher dividend yield at 6.64% vs WST's 0.26%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $315.83 | $169.67 | $193.81 | $43.50 | $50.00 |
| # AnalystsCovering analysts | 14 | 18 | 37 | 27 | 13 |
| Dividend YieldAnnual dividend ÷ price | +0.3% | +1.4% | +0.3% | +1.9% | +6.6% |
| Dividend StreakConsecutive years of raises | 25 | 33 | 1 | 0 | 11 |
| Dividend / ShareAnnual DPS | $0.84 | $1.81 | $0.60 | $0.81 | $2.65 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.6% | +4.5% | 0.0% | 0.0% | +0.7% |
WST leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). SEE leads in 1 (Valuation Metrics). 2 tied.
WST vs ATR vs GTLS vs SEE vs AMCR: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is WST or ATR or GTLS or SEE or AMCR a better buy right now?
For growth investors, Amcor plc (AMCR) is the stronger pick with 10.
0% revenue growth year-over-year, versus -0. 6% for Sealed Air Corporation (SEE). Sealed Air Corporation (SEE) offers the better valuation at 12. 3x trailing P/E (12. 4x forward), making it the more compelling value choice. Analysts rate West Pharmaceutical Services, Inc. (WST) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — WST or ATR or GTLS or SEE or AMCR?
On trailing P/E, Sealed Air Corporation (SEE) is the cheapest at 12.
3x versus Chart Industries, Inc. at 628. 5x. On forward P/E, Amcor plc is actually cheaper at 10. 1x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: AptarGroup, Inc. wins at 1. 75x versus Sealed Air Corporation's 9. 73x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — WST or ATR or GTLS or SEE or AMCR?
Over the past 5 years, Amcor plc (AMCR) delivered a total return of +320.
1%, compared to -19. 1% for Sealed Air Corporation (SEE). Over 10 years, the gap is even starker: GTLS returned +772. 5% versus SEE's +4. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — WST or ATR or GTLS or SEE or AMCR?
By beta (market sensitivity over 5 years), Sealed Air Corporation (SEE) is the lower-risk stock at 0.
32β versus West Pharmaceutical Services, Inc. 's 0. 92β — meaning WST is approximately 183% more volatile than SEE relative to the S&P 500. On balance sheet safety, West Pharmaceutical Services, Inc. (WST) carries a lower debt/equity ratio of 13% versus 3% for Sealed Air Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — WST or ATR or GTLS or SEE or AMCR?
By revenue growth (latest reported year), Amcor plc (AMCR) is pulling ahead at 10.
0% versus -0. 6% for Sealed Air Corporation (SEE). On earnings-per-share growth, the picture is similar: Sealed Air Corporation grew EPS 89. 5% year-over-year, compared to -92. 0% for Chart Industries, Inc.. Over a 3-year CAGR, GTLS leads at 38. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — WST or ATR or GTLS or SEE or AMCR?
West Pharmaceutical Services, Inc.
(WST) is the more profitable company, earning 16. 1% net margin versus 1. 0% for Chart Industries, Inc. — meaning it keeps 16. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: WST leads at 20. 1% versus 6. 7% for AMCR. At the gross margin level — before operating expenses — WST leads at 35. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is WST or ATR or GTLS or SEE or AMCR more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, AptarGroup, Inc. (ATR) is the more undervalued stock at a PEG of 1. 75x versus Sealed Air Corporation's 9. 73x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Amcor plc (AMCR) trades at 10. 1x forward P/E versus 37. 3x for West Pharmaceutical Services, Inc. — 27. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ATR: 35. 6% to $169. 67.
08Which pays a better dividend — WST or ATR or GTLS or SEE or AMCR?
All stocks in this comparison pay dividends.
Amcor plc (AMCR) offers the highest yield at 6. 6%, versus 0. 3% for West Pharmaceutical Services, Inc. (WST).
09Is WST or ATR or GTLS or SEE or AMCR better for a retirement portfolio?
For long-horizon retirement investors, Sealed Air Corporation (SEE) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
32), 1. 9% yield). Both have compounded well over 10 years (SEE: +4. 4%, WST: +361. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between WST and ATR and GTLS and SEE and AMCR?
These companies operate in different sectors (WST (Healthcare) and ATR (Healthcare) and GTLS (Industrials) and SEE (Consumer Cyclical) and AMCR (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: WST is a mid-cap quality compounder stock; ATR is a small-cap quality compounder stock; GTLS is a small-cap quality compounder stock; SEE is a small-cap deep-value stock; AMCR is a mid-cap income-oriented stock. ATR, SEE, AMCR pay a dividend while WST, GTLS do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.